Back to RHUMBLINE ADVISERS RHUMBLINE ADVISERS

SCNISCNI
9 quarters

Position history for RHUMBLINE ADVISERSRHUMBLINE ADVISERS's holdings in SCINAI IMMUNOTHERAPEUTICS LT

RHUMBLINE ADVISERS holds 13,513 shares of SCNI (SCINAI IMMUNOTHERAPEUTICS LT), worth $3,417 as of 2026-Q2. The position was increased (+619.5% shares).

Current Value

$3,417

Current Shares

13,513

Total Value Change

+$177

Total Shares Change

+12,375

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
13,513
+619.5%
$3,4170.0%$0.25
15
2026-Q1
Unchanged
1,878
0.0%
$1,0370.0%$0.80
0
2025-Q4
Decreased
1,878
-47.1%
$1,3350.0%$0.72
0
2025-Q3
Increased
3,553
+2.0%
$4,4920.0%$1.20
10
2025-Q2
Increased
3,483
+122.3%
$7,9750.0%$2.28
18
2025-Q1
Decreased
1,567
-5.2%
$4,1740.0%$2.80
0
2024-Q4
Unchanged
1,653
0.0%
$5,5010.0%$3.36
0
2024-Q3
Increased
1,653
+45.3%
$5,8480.0%$3.64
14
2024-Q2
New
1,138
-
$3,2400.0%$2.78
21

Other major holders of SCNI: UBS Group AG, CITADEL ADVISORS LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used